欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/H/0577/001
药品名称CARMYNE 40 mg/5 mL, solution for injection
活性成分
    • INDIGO CARMINE (E-132) 40.0 mg/5ml
剂型Solution for injection
上市许可持有人SERB S.A.S.
参考成员国 - 产品名称France (FR)
Carmynemg/5ml, solution injectable NL41987
互认成员国 - 产品名称
    • Germany (DE)
      CARMYNE 40 mg/5 mL, Injektionslösung
    • Belgium (BE)
      Carmin d’indigo Serb 40 mg/5 mL, solution injectable
    • Netherlands (NL)
    • Luxembourg (LU)
      Carmin d'indigo Serb, 40 mg /5 mL, Solution injectable
    • United Kingdom (Northern Ireland) (XI)
    • Denmark (DK)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
许可日期2015/05/11
最近更新日期2024/12/13
药物ATC编码
    • V04CH02 indigo carmine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase